Certain inflammatory markers such as ESR, PCT, CRP, and other markers were found to positively correlate with the severity of COVID-19; and CRP was described as a sensitive systemic marker of acute-phase response during inflammation and tissue damage, which could be used as an indicator of COVID-19 progress [8]. This evidence concerns the gene ESR1 and COVID-19.